Resuts:

Publications



2008

Ahmann G.J., Chng W.J., Henderson K.J., Price-Troska T.L., DeGoey R.W., Timm M.M., Dispenzieri A., Greipp P.R., Sable-Hunt A., Bergsagel L., Fonseca R. Effect of tissue shipping on plasma cell isolation, viability, and RNA integrity in the context of a centralized good laboratory practice-certified tissue banking facility. 2008, Cancer Epidemiology, Biomarkers & Prevention. 17(3):666-73.

 

2007

Stewart A.K., Chang H., Trudel S., Anderson K.C., Richardson P., Alsina M., Reece D., Young S., Sable-Hunt A., Li Z., Keats J., Van Wier S., Ahmann G., Price-Troska T., Giusti K, Bergsagel P.L., Chesi M. and Fonseca M. (2007). Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution. Leukemia. 11, 2358-9.

 

2006

Anderson K.C., Vesole D.H. (2006). Stem cell transplant for first relapse from the Multiple Myeloma Research Foundation. Oncology, 20(14):1818, 1820-1, 1825-6.


Lonial S., the Multiple Myeloma Research Foundation. (2006). Management of toxicities associated with bortezomib. Oncology, 20(12):1592-3, 1597.


Richardson P. (2006). Newer treatment options for patients in first relapse. From the Multiple Myeloma Research Foundation. Oncology, 20(6):633-8.

 

2005

Anderson K.C., Palumbo A., the Multiple Myeloma Research Foundation. (2005). Treatment options for older myeloma patients. From the Multiple Myeloma Research Foundation. Oncology, 19(4):447-50.


Orlowski R.Z., the Multiple Myeloma Research Foundation. (2005). Bortezomib therapy following first relapse. Oncology, 19(1):23-6.


Rajkumar V.S., the Multiple Myeloma Research Foundation. (2005). Treatment options and considerations for the newly diagnosed myeloma patient. Oncology, 19(10):1260, 1262, 1267 passim.


Roodman G.D., the Multiple Myeloma Research Foundation. (2005). Myeloma bone disease: pathogenesis and treatment. Oncology, 19(8):983-4, 986.

 

2004

Anderson K.C., the Multiple Myeloma Research Foundation. (2004). Novel immunomodulatory therapies in the treatment of multiple myeloma. Oncology, 18(8):988-90.


Greipp P., the Multiple Myeloma Research Foundation. (2004). Prognostic indicators for the diagnosis of multiple myeloma. Oncology, 18(5):558-60.


Harousseau J.L. (2004). New strategies in transplantation therapy. Oncology, 18(13):1614-5, 1617.


Hussein M.A., the Multiple Myeloma Research Foundation. (2004).  Salvage therapy options for myeloma patients. Oncology, 18(10):1233-5.

 

2003

Richardson P. (2003) Novel strategies in the treatment of relapsed/refractory multiple myeloma. From the Multiple Myeloma Research Foundation. Oncology, 17(8):1063-5.


Weber D.M. (2003). Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation. Oncology, 17(6):765-7.

 


2002


Anderson K.C., Dalton W.S. (2002). Synopsis of a research roundtable presented on cell signaling in myeloma: regulation of growth and apoptosis--opportunities for new drug discovery. Molecular Cancer Therapeutics, 1(14):1361-5.